• How fast the market of your interest is growing?

    How fast the market of your interest is growing?

    Key drivers behind the growth..

  • What are your biggest Challenges?
    What are your biggest Challenges?
    Identify the key problems..
  • What are your Revenue pockets?
    What are your Revenue pockets?
    Areas you need to bet..
  • What are your Competitors doing?
    What are your Competitors doing?
    Know your competitive edge..
  • Who is your Customer?
    Who is your Customer?
    Get Their changing preferences..
what we offer

Report Store

Healthcare is an ever changing domain with an explosion in knowledge and breakthrough discoveries. Hence, it has become a major thrust area for the global giants in the pharmaceutical, biotechnology and medical devices industries and also for corporates involved in research and development of new products.

IQ4I's focus areas in Healthcare include Pharmaceuticals, biotechnology, Medical devices and Healthcare IT. Since these domains cater to humans, they are subject to stringent regulatory mechanisms requiring highly specialized skills in knowledge processing, with superior quality and adherence to global standards.

IQ4I

Latest Reports

Factors like escalation of AI as a medical device, increasing prevalence of chronic, communicable diseases and escalating geriatric population and the increasing trend of acquisitions, collaborations, investments in the AI in healthcare market are further substantiating the enormous growth opportunities of the market
View Details
The factors driving the genomics market are demand for early disease detection, diagnosis, and treatment, rising government and private funding, increasing awareness and reduced cost of genomics test, favorable reimbursement, increasing demand for personalized medicine, increasing utilization of genomic technologies in drug discovery & development and technological advancements.
View Details
Some of the factors driving the market are increase in incidence and prevalence of neurovascular diseases like cerebral aneurysm, stroke, arteriovenous malformations, and increase in the aging population, technological advancement, acquisitions and favourable reimbursements.
View Details
This report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery, preclinical development, clinical phases and commercial manufacturing of biologics.
View Details
Technological advancements in cell line engineering (gene editing tools) & cell line development technologies, screening technologies and process development are giving immense growth opportunities for the market
View Details
The contract biomanufacturing global market is driven by the increasing trend of outsourcing among the biopharmaceutical companies, availability of advanced bioprocessing capabilities among the contract bioservice providers and the escalating approval and adoption of biologics and the cost effective biosimilars among the value centric global patient pool leading to huge volume demand for biologics
View Details
Increasing need in emerging markets, production of radiopharmaceuticals from cyclotrons, efficient diagnosis and treatments, emerging radioisotopes and replacement of old/traditional equipment are the opportunities likely to propel the growth of the nuclear medicine market.
View Details
An increasing number of patients suffering from obesity and the rise in the aging population who are vulnerable to develop hernia, rising adoption of tension-free repair procedures and increasing demand for minimally invasive procedures, are driving the growth of hernia repair devices market.
View Details
Increasing prevalence of infectious diseases, requirement of early detection of infectious disease, increasing point of care diagnostics and rapid diagnostics, favourable reimbursements, technological advancements and rising investments in diagnostics are driving the market
View Details
Some of the factors such as increasing population prone to aging-related medical conditions, increasing R&D spending for developing innovative and technologically advanced products, and also the development of more personalized products for greater patient comfort and care are driving the market growth
View Details
IQ4I

Latest News

Artificial Intelligence in Healthcare Global Market estimated to be worth $35.3 billion by 2027

The potential of AI to seamlessly assist and guide the healthcare personnel in arriving at the accurate, precise and rapid diagnostic or therapeutic conclusions, to improve patient care, to empower individuals in their self-care, to optimize the various administrative tasks of healthcare organizations effecti...

continue reading

Genomics Global Market is estimated to be worth $31.8 billion by 2027.

The factors driving the genomics market are demand for early disease detection, diagnosis, and treatment, rising government and private funding, increasing awareness and reduced cost of genomics test, favorable reimbursement, increasing demand for personalized medicine, increasing utilization of genomic techn...

continue reading
IQ4I

Clientele

Offering solutions to >500 clients from the U.S., Europe, Japan, Korea, Singapore and Australia in realizing the market potential and competitive intelligence across healthcare domains (Medical Technologies, Pharmaceutical, Biotech and Life Sciences).

IQ4I

clients testimonials

  • Before finalizing IQ4I's report we have considered our options for various market reports, but all the reports lack in some or the other part, which is quite crucial for our business. We are looking for information sources that can help us triangulate data that we collect on our own. IQ4I report intrigues me and my team enough that we had further explored by requesting a customized sample. Information what Iq4I provided was almost matching with our research.

  • IQ4I helped us in geographic based mapping of Pharmaceutical & biotech companies, academic institutes and spin-offs, healthcare providers focusing to develop innovative solutions to global healthcare problems. They understood our partnering areas of interest very well and provided a detailed presentation. Good job!!

  • Our association started with a small pilot project and now they are providing us drug pipeline reports on regular basis. The best thing about IQ4I reports is that we can ask for customization and they cover all treatment modalities. IQ4I is highly flexible and approachable.

  • We are really happy with the content and quality of the report. Thank you for your support and the customization on this report. We will be using this report for a variety of our public communications.

  • We believe our hunt for a consulting firm ends here, which understands the discovery outsourcing market thoroughly. Their insights on competitive intelligence were of great help to us.

  • These numbers are clearly far more accurate as they are very close to the numbers we have in our analysis based on populations. This makes them valuable and immediately useful.